SkinBioTherapeutics Statistics

Total Valuation

AIM:SBTX has a market cap or net worth of GBP 39.14 million. The enterprise value is 35.35 million.

Market Cap	39.14M
Enterprise Value	35.35M

Important Dates

The last earnings date was Tuesday, December 2, 2025.

Earnings Date	Dec 2, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM:SBTX has 258.78 million shares outstanding. The number of shares has increased by 20.57% in one year.

Current Share Class	258.78M
Shares Outstanding	258.78M
Shares Change (YoY)	+20.57%
Shares Change (QoQ)	+13.96%
Owned by Insiders (%)	19.89%
Owned by Institutions (%)	67.98%
Float	165.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.44
PB Ratio	4.16
P/TBV Ratio	7.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-50.78
EV / Sales	7.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-28.48

Financial Position

The company has a current ratio of 4.84, with a Debt / Equity ratio of 0.11.

Current Ratio	4.84
Quick Ratio	4.29
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	-0.80
Interest Coverage	-12.21

Financial Efficiency

Return on equity (ROE) is -11.24% and return on invested capital (ROIC) is -9.89%.

Return on Equity (ROE)	-11.24%
Return on Assets (ROA)	-8.10%
Return on Invested Capital (ROIC)	-9.89%
Return on Capital Employed (ROCE)	-10.54%
Revenue Per Employee	309,210
Profits Per Employee	-46,417
Employee Count	15
Asset Turnover	0.53
Inventory Turnover	2.80

Taxes

Income Tax	-18,863
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.79% in the last 52 weeks. The beta is 0.64, so AIM:SBTX's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	-14.79%
50-Day Moving Average	15.63
200-Day Moving Average	17.89
Relative Strength Index (RSI)	39.30
Average Volume (20 Days)	1,004,420

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:SBTX had revenue of GBP 4.64 million and -696,253 in losses. Loss per share was -0.00.

Revenue	4.64M
Gross Profit	2.86M
Operating Income	-1.12M
Pretax Income	-715,116
Net Income	-696,253
EBITDA	-818,746
EBIT	-1.12M
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 4.78 million in cash and 993,466 in debt, giving a net cash position of 3.79 million or 0.01 per share.

Cash & Cash Equivalents	4.78M
Total Debt	993,466
Net Cash	3.79M
Net Cash Per Share	0.01
Equity (Book Value)	9.42M
Book Value Per Share	0.04
Working Capital	5.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.24 million and capital expenditures -6,300, giving a free cash flow of -1.24 million.

Operating Cash Flow	-1.24M
Capital Expenditures	-6,300
Free Cash Flow	-1.24M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 61.65%, with operating and profit margins of -24.22% and -15.01%.

Gross Margin	61.65%
Operating Margin	-24.22%
Pretax Margin	-15.42%
Profit Margin	-15.01%
EBITDA Margin	-17.65%
EBIT Margin	-24.22%
FCF Margin	n/a

Dividends & Yields

AIM:SBTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.57%
Shareholder Yield	-20.57%
Earnings Yield	-1.78%
FCF Yield	-3.17%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4